Table 1.

Clinico-pathological parameters of all 109 bladder cancer specimens analyzed in this study (RT-PCR/MSP/immunohistochemistry)

	Categorization	n aanalyzable	%
Parameter:
Age at diagnosis:	Median: 69 years
	(range 26–94)
	≤69 years	55	50.5
	>69 years	54	49.5
Gender
	Female	29	26.6
	Male	80	73.4
Tumor subtype
	Carcinoma in situ	13	11.9
	Papillary non-invasive	17	15.6
	Invasive	79	72.5
Histological tumor gradeb
	G1	14	12.8
	G2	9	8.3
	G3	80	73.4
	unknown	6	5.5
Histological tumor gradec
	Low grade	15	13.8
	High grade	94	86.2
Tumor stagec
	pTx	1	0.9
	pTis	13	11.9
	pTa	16	14.7
	pT1	12	11.0
	pT2	25	22.9
	pT3	31	28.4
	pT4	11	10.1
Concomitant CIS
	Negative	26	23.9
	Positive	52	47.7
	Unknown	31	28.4
Lymph node status
	Negative	41	37.6
	Positive	18	16.5
	Unknown	50	45.9

^aOnly patients with primary bladder cancer were included; ^baccording to WHO 1973 classification; ^caccording to WHO 2004 classification.